Transitory tyrosinaemia of newborn (Q45883): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: P74.5 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:08, 13 August 2026
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KB63.4 |
||
| English | Transitory tyrosinaemia of newborn |
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age. |
Statements
CID11:KB63.4
0 references
dki-india-KB63.4
0 references
Concluído
0 references
13 August 2026
0 references
